Sharp Therapeutics Corp. (TSXV:SHRX)

Canada flag Canada · Delayed Price · Currency is CAD
1.850
0.00 (0.00%)
At close: Apr 30, 2025
-15.91%
Market Cap 55.39M
Revenue (ttm) n/a
Net Income (ttm) -7.60M
Shares Out 29.94M
EPS (ttm) -0.47
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 200
Average Volume 2,837
Open 1.850
Previous Close 1.850
Day's Range 1.850 - 1.850
52-Week Range 0.800 - 2.280
Beta n/a
RSI 46.91
Earnings Date Aug 21, 2025

About Sharp Therapeutics

Sharp Therapeutics Corp., a preclinical-stage drug discovery company, developes therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies, enables discovery of compounds that correct the mutational defect; AlloChem, a compound library, binds proteins allosterically, thus stabilizing and activating them; And Mine, a proprietary IP-protected analytics platform, captures all data for all AlloChem compounds in all CoreX assays. Sharp Therapeutics Corp. is headquartered in Pittsburgh, Pen... [Read more]

Industry Biotechnology
Sector Healthcare
CEO Scott Sneddon
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol SHRX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.